Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2006

01.04.2006 | Article

Clinical significance of bacteriuria with low colony counts of Enterococcus species

verfasst von: R. Colodner, T. Eliasberg, B. Chazan, R. Raz

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

The clinical significance of low counts of enterococci in urine cultures remains unclear. The goal of this study was to investigate the clinical significance of enterococci growing in numbers lower than 100,000 colony-forming units per milliliter (cfu/ml) in urine samples. Clinical parameters were collected from patients whose midstream clean-catch urine samples grew Enterococcus spp. in amounts between ≥10,000 and 100,000 cfu/ml and who were not previously treated with antibiotics. Only those patients who had leukocyturia in addition to positive culture were considered to have true urinary tract infection (UTI). Of the 208 patients included in the study, 54% were diagnosed with true UTI. Patients with true UTI were older by 6 years (p=0.03), were more likely to be hospitalized (p=0.016), had higher rates of dysuria (p=0.0001), urgency (p=0.0001), and frequency (p=0.0001), and had more solid tumors (p=0.03). By multivariate analysis, urgency (OR=7.1) and hospitalization (OR=4.4) were identified as independent risk factors for true UTI with enterococci in low counts. Enterococcal counts in patients with true UTI were randomly distributed all along the scale between 10,000 and 100,000 cfu/ml, and no differential cutoff could be determined. In conclusion, more than half of the patients whose urine cultures grow Enterococcus spp. in counts lower than 100,000 cfu/ml may have true UTI, especially if they are hospitalized and have symptoms of dysuria, urgency, or frequency. Microbiology laboratories should perform a complete work-up on samples containing low counts of enterococci, and the final interpretation should be done by physicians, using additional clinical information.
Literatur
1.
Zurück zum Zitat Patton JP, Nash DB, Abrytyn E (1991) Urinary tract infection: economic considerations. Med Clin North Am 75:495–513PubMed Patton JP, Nash DB, Abrytyn E (1991) Urinary tract infection: economic considerations. Med Clin North Am 75:495–513PubMed
2.
Zurück zum Zitat Kass EH, Finland M (1956) Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 69:56–64PubMed Kass EH, Finland M (1956) Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 69:56–64PubMed
3.
Zurück zum Zitat Stamm WE, Hooton M (1993) Management of urinary tract infections in adults. N Engl J Med 329:1328–1334CrossRefPubMed Stamm WE, Hooton M (1993) Management of urinary tract infections in adults. N Engl J Med 329:1328–1334CrossRefPubMed
4.
Zurück zum Zitat Lipsky A (1999) Prostatitis and urinary tract infections in men: what’s new, what’s true? Am J Med 106:327–334CrossRefPubMed Lipsky A (1999) Prostatitis and urinary tract infections in men: what’s new, what’s true? Am J Med 106:327–334CrossRefPubMed
5.
Zurück zum Zitat Moellering RC Jr (1992) Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14:1173–1176PubMed Moellering RC Jr (1992) Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14:1173–1176PubMed
6.
Zurück zum Zitat Felmingham D, Wilson AP, Quintana AI, Gruneberg RN (1992) Enterococcus species in urinary tract infection. Clin Infect Dis 15:295–301PubMed Felmingham D, Wilson AP, Quintana AI, Gruneberg RN (1992) Enterococcus species in urinary tract infection. Clin Infect Dis 15:295–301PubMed
7.
Zurück zum Zitat Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 28:435–437PubMed Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 28:435–437PubMed
8.
Zurück zum Zitat Jones RN, Kugler KC, Pfaller MA, Winokur PL (1999) Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 35:55–63CrossRefPubMed Jones RN, Kugler KC, Pfaller MA, Winokur PL (1999) Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 35:55–63CrossRefPubMed
9.
Zurück zum Zitat Griebling TL (2005) Urologic Diseases in America Project: trends in resource use for urinary tract infections in women. J Urol 173:1281–1287CrossRefPubMed Griebling TL (2005) Urologic Diseases in America Project: trends in resource use for urinary tract infections in women. J Urol 173:1281–1287CrossRefPubMed
10.
Zurück zum Zitat Mathai D, Jones RN, Pfaller MA, and the SENTRY Participant Group North America (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40:129–136CrossRefPubMed Mathai D, Jones RN, Pfaller MA, and the SENTRY Participant Group North America (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40:129–136CrossRefPubMed
11.
Zurück zum Zitat Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL (2005) Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9:R60–R65CrossRefPubMed Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL (2005) Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9:R60–R65CrossRefPubMed
12.
Zurück zum Zitat Laupland KB, Zygun DA, Davis HD, Church DL, Louie TJ, Doig CJ (2002) Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 17:50–57CrossRefPubMed Laupland KB, Zygun DA, Davis HD, Church DL, Louie TJ, Doig CJ (2002) Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 17:50–57CrossRefPubMed
13.
Zurück zum Zitat Langley JM, Hanakowski M, Leblanc JC (2001) Unique epidemiology of nosocomial urinary tract infection in children. Am J Infect Control 29:94–98CrossRefPubMed Langley JM, Hanakowski M, Leblanc JC (2001) Unique epidemiology of nosocomial urinary tract infection in children. Am J Infect Control 29:94–98CrossRefPubMed
14.
Zurück zum Zitat Moulin F, Quintart A, Sauvestre C, Mensah K, Bergeret M, Raymond J (1998) Nosocomial urinary tract infections: retrospective study in a pediatric hospital. Arch Pediatr 5(Suppl 3):274S–278SCrossRefPubMed Moulin F, Quintart A, Sauvestre C, Mensah K, Bergeret M, Raymond J (1998) Nosocomial urinary tract infections: retrospective study in a pediatric hospital. Arch Pediatr 5(Suppl 3):274S–278SCrossRefPubMed
15.
Zurück zum Zitat Morrison AJ Jr, Wenzel RP (1986) Nosocomial urinary tract infections due to enterococcus. Ten years experience at a university hospital. Arch Intern Med 146:1549–1551CrossRefPubMed Morrison AJ Jr, Wenzel RP (1986) Nosocomial urinary tract infections due to enterococcus. Ten years experience at a university hospital. Arch Intern Med 146:1549–1551CrossRefPubMed
16.
Zurück zum Zitat Bitsori M, Maraki S, Raissaki M, Bakantaki A, Galanakis E (2005) Community-acquired enterococcal urinary tract infections. Pediatr Nephrol 20:1583–1586CrossRefPubMed Bitsori M, Maraki S, Raissaki M, Bakantaki A, Galanakis E (2005) Community-acquired enterococcal urinary tract infections. Pediatr Nephrol 20:1583–1586CrossRefPubMed
17.
Zurück zum Zitat Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113(Suppl 1A):14S–19SCrossRefPubMed Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113(Suppl 1A):14S–19SCrossRefPubMed
18.
Zurück zum Zitat Tailor SA, Bailey EM, Rybak MJ (1993) Enterococcus, an emerging pathogen. Ann Pharmacother 27:1231–1242PubMed Tailor SA, Bailey EM, Rybak MJ (1993) Enterococcus, an emerging pathogen. Ann Pharmacother 27:1231–1242PubMed
19.
Zurück zum Zitat Wong AH, Wenzel RP, Edmond MB (2000) Epidemiology of bacteriuria caused by vancomycin-resistant enterococci—a retrospective study. Am J Infect Control 28:277–281CrossRefPubMed Wong AH, Wenzel RP, Edmond MB (2000) Epidemiology of bacteriuria caused by vancomycin-resistant enterococci—a retrospective study. Am J Infect Control 28:277–281CrossRefPubMed
20.
Zurück zum Zitat Hooton TM (1990) The epidemiology of urinary tract infection and the concept of significant bacteriuria. Infection 18(Suppl 2):S40–S43CrossRefPubMed Hooton TM (1990) The epidemiology of urinary tract infection and the concept of significant bacteriuria. Infection 18(Suppl 2):S40–S43CrossRefPubMed
21.
Zurück zum Zitat Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM (2004) Int J Clin Pharmacol Ther 42:360–366PubMed Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM (2004) Int J Clin Pharmacol Ther 42:360–366PubMed
22.
Zurück zum Zitat Barnett BJ, Stephens DS (1997) Urinary tract infection: an overview. Am J Med Sci 314:245–249CrossRefPubMed Barnett BJ, Stephens DS (1997) Urinary tract infection: an overview. Am J Med Sci 314:245–249CrossRefPubMed
Metadaten
Titel
Clinical significance of bacteriuria with low colony counts of Enterococcus species
verfasst von
R. Colodner
T. Eliasberg
B. Chazan
R. Raz
Publikationsdatum
01.04.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2006
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0132-0

Weitere Artikel der Ausgabe 4/2006

European Journal of Clinical Microbiology & Infectious Diseases 4/2006 Zur Ausgabe

Announcements

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.